PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmaceutical Sciences School of Pharmacy and Pharmaceutical Sciences Binghamton University, Johnson City, NY, 13790, USA. Electronic address: eernst1@binghamton.edu.\', \'Department of Pharmaceutical Sciences School of Pharmacy and Pharmaceutical Sciences Binghamton University, Johnson City, NY, 13790, USA. Electronic address: pwolfe@binghamton.edu.\', \'Department of Pharmaceutical Sciences School of Pharmacy and Pharmaceutical Sciences Binghamton University, Johnson City, NY, 13790, USA. Electronic address: cstahur1@binghamton.edu.\', \'Department of Pharmaceutical Sciences School of Pharmacy and Pharmaceutical Sciences Binghamton University, Johnson City, NY, 13790, USA. Electronic address: kedwards@binghamton.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0039-9140(20)31174-710.1016/j.talanta.2020.121883
?:hasPublicationType
?:journal
  • Talanta
is ?:pmid of
?:pmid
?:pmid
  • 33379092
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.186
?:rankingScore_hIndex
  • 141
?:title
  • Technical considerations to development of serological tests for SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33379092>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33379092>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all